Hereditary Hemorrhagic Telangiectasia (HHT) Center

Closed

Health Resources and Services Administration

Description

The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year (FY) 2022 Hereditary Hemorrhagic Telangiectasia (HHT) Center. The purpose of the program is to reduce morbidity and mortality associated with hereditary hemorrhagic telangiectasia by funding a national center to: 1) expand access to and coordination of care for HHT patients; and 2) develop a de-identified, aggregate data collection registry to better understand this rare disease and treatment outcomes.

Who can apply

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Native American tribal governments (Federally recognized)
  • Native American tribal organizations (other than Federally recognized)
  • Nonprofits with 501(c)(3) status (other than higher education)
  • For-profit organizations other than small businesses
  • Small businesses
  • Others

Contact

Department of Health and Human Services, Health Resources and Services Administration<br/>cnovoa@hrsa.gov
cnovoa@hrsa.gov

Key dates & funding
  • PostedMar 18, 2022
  • ClosesMay 17, 2022
  • Award floor$0
  • Award ceiling$2,000,000
  • Program funding$2,000,000
  • Expected awards1
  • CFDA93.110
Categories

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro